10 completed, 3 recruiting, 2 terminated, 1 unknown. 17 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 17 | Completed 10, Recruiting 3, Terminated 2, Unknown 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Primary Sclerosing Cholangitis: new trials by email Literature Review of Primary Sclerosing Cholangitis trials Research Report on Primary Sclerosing Cholangitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC) TAK-781, Placebo - Healthy Volunteers, Primary Sclerosing Cholangitis | Phase 1 | Recruiting | Takeda | 134 | 2026-01-07 | 2026-03-05 |
| A Study of SIPLIZUMAB in AILD and LT Patients Siplizumab - Autoimmune Liver Disease, Liver Transplant Disorder | Phase 1 | Recruiting | Elizabeth C. Verna | 8 | 2024-09-11 | 2025-11-24 |
| Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis Cilofexor - Primary Sclerosing Cholangitis, Compensated Cirrhosis | Phase 1 | Terminated | Gilead Sciences | 11 | 2019-10-17 | 2023-07-27 |
| A Study Of Ursolic Acid For Primary Sclerosing Cholangitis Ursolic acid - Primary Sclerosing Cholangitis | Phase 1 | Withdrawn | University of California, Davis | 2017-09-01 | 2017-07-25 | |
| A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC) Curcumin - Primary Sclerosing Cholangitis | Phase 1 / Phase 2 | Completed | John E. Eaton | 15 | 2017-06-09 | 2020-01-18 |
| A Study of HTD1801 in Healthy Subjects HTD1801 - Primary Sclerosing Cholangitis | Phase 1 | Completed | HighTide Therapeutics (Hong Kong) Limited | 32 | 2017-03-24 | 2026-08-11 |
| Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis UCMSC, UDCA - Primary Sclerosing Cholangitis | Phase 1 / Phase 2 | Unknown | Fuzhou General Hospital | 20 | 2017-01-01 | 2018-05-04 |
| A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis Vancomycin - Primary Sclerosing Cholangitis, Inflammatory Bowel Disease | Phase 1 | Completed | University of Minnesota | 8 | 2015-07-01 | 2020-07-17 |
| Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT 11C-CSar, ICG - Cholestasis, Primary Sclerosing Cholangitis | Phase 1 | Completed | University of Aarhus | 22 | 2013-06-01 | 2015-02-23 |
| Pilot Study of Fenofibrate for PSC fenofibrate - Primary Sclerosing Cholangitis | Phase 1 / Phase 2 | Terminated | University of Miami | 8 | 2010-10-01 | 2018-02-06 |
| Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis ursodeoxycholic acid (UDCA) - Primary Sclerosing Cholangitis | Phase 1 | Completed | University of Tennessee | 27 | 2010-10-01 | 2017-10-26 |
| Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin Oral Vancomycin - Primary Sclerosing Cholangitis, Biliary Atresia | Phase 1 | Recruiting | Sacramento Pediatric Gastroenterology | 200 | 2010-07-01 | 2016-11-15 |
| A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis Vancomycin, Metronidazole - Primary Sclerosing Cholangitis | Phase 1 | Completed | Mayo Clinic | 35 | 2010-02-01 | 2013-09-19 |
| Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC) Erlotinib (Tarceva) - Primary Sclerosing Cholangitis, Trisomy 7 | Phase 1 | Completed | Mayo Clinic | 6 | 2009-08-01 | 2014-01-10 |
| Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin Vancomycin - Primary Sclerosing Cholangitis, Biliary Atresia | Phase 1 | Completed | Stanford University | 32 | 2007-05-01 | 2016-05-18 |
| Evaluation of DHA for the Treatment of PSC Docosahexaenoic Acid (DHA) - Primary Sclerosing Cholangitis, Colitis | Phase 1 | Completed | Beth Israel Deaconess Medical Center | 10 | 2005-12-01 | 2015-03-11 |
| Minocycline in Primary Sclerosing Cholangitis (PSC) Minocycline - Primary Sclerosing Cholangitis | Phase 1 | Completed | Mayo Clinic | 16 | 2003-02-01 | 2010-12-07 |
Cholangitis, Sclerosing (17) · Biliary Atresia (2) · Hepatitis, Autoimmune (2) · Cholangiocarcinoma (1) · Cholestasis (1) · Colitis (1) · End Stage Liver Disease (1) · Fibrosis (1) · Inflammatory Bowel Diseases (1) · Liver Cirrhosis (1) · Liver Cirrhosis, Biliary (1)
Bile Duct Diseases (17) · Biliary Tract Diseases (17) · Cholangitis (17) · Digestive System Diseases (17) · Liver Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Autoimmune Diseases (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Abnormalities (2) · Fibrosis (2) · Gastroenteritis (2) · Gastrointestinal Diseases (2) · Hepatitis (2)
Vancomycin (4) · Curcumin (1) · Docosahexaenoic Acids (1) · Erlotinib Hydrochloride (1) · Fenofibrate (1) · Fish Oils (1) · Indocyanine Green (1) · Metronidazole (1) · Minocycline (1) · Ursodeoxycholic Acid (1) · Ursolic Acid (1) · cholylsarcosine (1) · cilofexor (1) · siplizumab (1)
Mayo Clinic (3) · Beth Israel Deaconess Medical Center (1) · Elizabeth C. Verna (1) · Fuzhou General Hospital (1) · Gilead Sciences (1) · HighTide Therapeutics (Hong Kong) Limited (1) · John E. Eaton (1) · Sacramento Pediatric Gastroenterology (1) · Stanford University (1) · Takeda (1) · University of Aarhus (1) · University of California, Davis (1) · University of Miami (1) · University of Minnesota (1) · University of Tennessee (1)
United States (13) · Australia (1) · Denmark (1)
Benjamin Shneider, M.D. (1) · Byron P Vaughn, MD (1) · Christopher Bowlus, MD (1) · Cynthia Levy, MD (1) · Dennis D Black, M.D. (1) · Elizabeth Verna, MD (1) · Janet Wong, Doctor (1) · Jayant A Talwalkar, MD (1) · Keith D. Lindor, M.D. (1) · Kenneth L Cox, MD (1) · Nicholas F LaRusso, M.D. (1) · Steve D Freedman, MD, PhD (1) · Susanne Keiding, M.D. D.Sc. (1)
PMID 23054338, PMID 23384404, PMID 28249726, PMID 32633158, PMID 38976363
R03DK071851 (1)